DULUTH, Ga., Sept. 10, 2019 /PRNewswire/ -- Lyme disease in dogs is caused by one of the fastest-growing tick-transmitted bacterial infections in the United States – and it can cause major health problems in dogs.

BIRMINGHAM, Ala., Sept. 10, 2019 /PRNewswire/ -- Yuva Biosciences, Inc., an anti-aging company developing cosmeceuticals as well as pharmaceuticals targeted at aging-associated hair loss, wrinkled skin, and reduced energy, today announced that Aubrey de Grey, Ph.D. and Frank L. Jaksch, Jr. have joined t

Second Annual Report Reinforces the Company's Continued Commitment to Responsible, Ethical and Sustainable Operations LAVAL, Quebec, Sept. 10, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today released its second annual

BOISE, Idaho, Sept. 10, 2019 /PRNewswire/ -- As part of its commitment to prevent opioid misuse, Albertsons Companies now offers

Company announces record Q3 2019 revenue guidance of $16 million – $17 million  KELOWNA, Sept. 10, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of indust

SUNNYVALE, Calif., Sept. 10, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Geisinger Medical Center radiation oncology team is first in Pennsylvania to treat cancer patients with the innovative

NEW YORK, Sept. 10, 2019 /PRNewswire/ -- Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that Paul Taheri, MD, MBA and currently CEO of Yale Medicine and a Deputy Dean for Clinical Affairs at the Yale School o

NEW HAVEN, Conn., Sept. 10, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biotechnology company focused on advancing innovative therapies for neurological and neuropsychiatric diseases, today announced completion of enrollment in its Phase 2/3, double-blind, randomized, placebo-controlled, dose-ranging trial of intranasally admini

WESTON, Florida, Sept. 10, 2019 /PRNewswire/ -- LeafyWell (LeafyWell.com), a subsidiary of NxGen Brands, Inc. (NXGB), today announces uniting with Shari Kaplan Stellino, founder and CEO of Cannectd Biotechnology, (

MENLO PARK, Calif., Sept. 10, 2019 /PRNewswire/ -- Ablacon, Inc. (www.ablacon.com), an Ajax Health-funded company, announced today the release of an updated version of its Ablamap technology u